Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment - A national drug abuse treatment clinical trials network study

被引:249
|
作者
Peirce, JM
Petry, NM
Stitzer, ML
Blaine, J
Kellogg, S
Satterfield, F
Schwartz, M
Krasnansky, J
Pencer, E
Silva-Vazquez, L
Kirby, KC
Roger-Malvestuto, C
Roll, JM
Cohen, A
Copersino, ML
Kolodner, K
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Univ Connecticut, Sch Med, New Haven, CT USA
[3] Biopharmaceut Res Consultants Inc, Ann Arbor, MI USA
[4] NYU, New York, NY USA
[5] Rockefeller Univ, New York, NY 10021 USA
[6] Univ Penn, Philadelphia, PA 19104 USA
[7] Treatment Res Inst, Philadelphia, PA USA
[8] Washington State Univ, Washington Inst Mental Illness Res & Training, Spokane, WA USA
[9] Univ Calif Los Angeles, Los Angeles, CA USA
[10] NIDA, Intramural Res Program, Baltimore, MD USA
关键词
D O I
10.1001/archpsyc.63.2.201
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Contingency management interventions that provide tangible incentives based on objective indicators of drug abstinence have improved treatment outcomes of substance abusers, but have not been widely implemented in community drug abuse treatment settings. Objective: To compare outcomes achieved when a lower-cost prize-based contingency management treatment is added to usual care in community methadone hydrochloride maintenance treatment settings. Design: Random assignment to usual care with (n = 198) or without (n = 190) abstinence incentives during a 12-week trial. Setting: Six community-based methadone maintenance drug abuse treatment clinics in locations across the United States. Participants: Three hundred eighty-eight stimulant-abusing patients enrolled in methadone maintenance programs for at least 1 month and no more than 3 years. Intervention: Participants submitting stimulant- and alcohol-negative samples earned draws for a chance to win prizes; the number of draws earned increased with continuous abstinence time. Main Outcome Measures: Total number of stimulant- and alcohol-negative samples provided, percentage of stimulant- and alcohol-negative samples provided, longest duration of abstinence, retention, and counseling attendance. Results: Submission of stimulant- and alcohol-negative samples was twice as likely for incentive as for usual care group participants (odds ratio, 1.98; 95% confidence interval, 1.42-2.77). Achieving 4 or more, 8 or more, and 12 weeks of continuous abstinence was approximately 3, 9, and 11 times more likely, respectively, for incentive vs usual care participants. Groups did not differ on study retention or counseling attendance. The average cost of prizes was $120 per participant. Conclusion: An abstinence incentive approach that paid $120 in prizes per participant effectively increased stimulant abstinence in community-based methadone maintenance treatment clinics.
引用
收藏
页码:201 / 208
页数:8
相关论文
共 50 条
  • [1] Infrequent illicit methadone use among stimulant-using patients in methadone maintenance treatment programs: A National Drug Abuse Treatment Clinical Trials Network study
    Wu, Li-Tzy
    Blazer, Dan G.
    Stitzer, Maxine L.
    Patkar, Ashwin A.
    Blaine, Jack D.
    AMERICAN JOURNAL ON ADDICTIONS, 2008, 17 (04): : 304 - 311
  • [2] Heterogeneity of Stimulant Dependence: A National Drug Abuse Treatment Clinical Trials Network Study
    Wu, Li-Tzy
    Blazer, Dan G.
    Patkar, Ashwin A.
    Stitzer, Maxine L.
    Wakim, Paul G.
    Brooner, Robert K.
    AMERICAN JOURNAL ON ADDICTIONS, 2009, 18 (03): : 206 - 218
  • [3] Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network
    Stitzer, Maxine L.
    Petry, Nancy M.
    Peirce, Jessica
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2010, 38 (04) : S61 - S69
  • [4] Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs - A national drug abuse treatment clinical trials network study
    Petry, NM
    Peirce, JM
    Stitzer, ML
    Blaine, J
    Roll, JM
    Cohen, A
    Obert, J
    Killeen, T
    Saladin, ME
    Cowell, M
    Kirby, KC
    Sterling, R
    Royer-Malvestuto, C
    Hamilton, J
    Booth, RE
    Macdonald, M
    Liebert, M
    Rader, L
    Burns, R
    DiMaria, J
    Copersino, M
    Stabile, PQ
    Kolodner, K
    ARCHIVES OF GENERAL PSYCHIATRY, 2005, 62 (10) : 1148 - 1156
  • [5] Treatment programs in the National Drug Abuse Treatment Clinical Trials Network
    McCarty, Dennis
    Fuller, Bret
    Kaskutas, Lee Ann
    Wendt, William W.
    Nunes, Edward V.
    Miller, Michael
    Forman, Robert
    Magruder, Kathryn M.
    Arfken, Cynthia
    Copersino, Marc
    Floyd, Anthony
    Sindelark, Jody
    Edmundson, Eldon
    DRUG AND ALCOHOL DEPENDENCE, 2008, 92 (1-3) : 200 - 207
  • [6] Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network
    Knudsen, Hannah K.
    Abraham, Amanda J.
    Johnson, J. Aaron
    Roman, Paul M.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2009, 37 (03) : 307 - 312
  • [7] THE NATIONAL-INSTITUTE-ON-DRUG-ABUSE AND METHADONE-MAINTENANCE TREATMENT
    SCHUSTER, CR
    JOURNAL OF PSYCHOACTIVE DRUGS, 1991, 23 (02) : 111 - 112
  • [8] Selection and utilization of assessment instruments in substance abuse treatment trials: the National Drug Abuse Treatment Clinical Trials Network experience
    Rosa, Carmen
    Ghitza, Udi
    Tai, Betty
    SUBSTANCE ABUSE AND REHABILITATION, 2012, 3 : 81 - 89
  • [9] Nurse turnover in substance abuse treatment programs affiliated with the National Drug Abuse Treatment Clinical Trials Network
    Knudsen, Hannah K.
    Abraham, Amanda J.
    Roman, Paul M.
    Studts, Jamie L.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2011, 40 (03) : 307 - 312
  • [10] Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network Check for study
    McClure, Erin A.
    Baker, Nathaniel L.
    Sonne, Susan C.
    Ghitza, Udi E.
    Tomko, Rachel L.
    Montgomery, LaTrice
    Babalonis, Shanna
    Terry, Garth E.
    Gray, Kevin M.
    DRUG AND ALCOHOL DEPENDENCE, 2018, 192 : 59 - 66